Leading global experts have combined guideline recommendations and new clinical data with practical, case-based formats that approximate clinical reality to improve patient outcomes in the management of heart failure. This series is focused on changing clinical behavior in the recognition and diagnoses of hyperkalemia and iron deficiency in heart failure, through the application of emerging science into everyday practice.
To return to the Global Heart Failure Academy, please click here.
This educational series is developed by Medtelligence. Supported by an unrestricted educational grant from CSL Vifor.
.png)
Pearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD
Pearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
Overcoming Clinical Inertia in Hyperkalemia Management
Overcoming Clinical Inertia in Hyperkalemia Management
Late-breaking First Response on AFFIRM-AHF
Late-breaking First Response on AFFIRM-AHF
CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy
CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy
Mechanisms in Heart Failure: Why Iron Deficiency Matters
Mechanisms in Heart Failure: Why Iron Deficiency Matters
Balancing RAASi Therapy and Potassium: Understanding How it Works
Balancing RAASi Therapy and Potassium: Understanding How it Works
